ArticleFrontiers in neuroscience2026
Therapeutic impact of Mongolian Andai therapy on gut microbiota and metabolomic profiles in depression.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Depression remains a leading global health issue, with many patients failing to respond to traditional treatments. Emerging research links depression to gut microbiota dysbiosis, suggesting a role for microbiota-based interventions. This study explores the effects of Mongolian Andai therapy on gut microbiota and metabolites in depressed patients. Methods: Twenty patients with depression underwent 8 weeks of Andai therapy. Gut microbiota was analyzed using 16S rRNA sequencing, and blood metabolites were analyzed through metabolomics. Bioinformatic analyses, including PCA and KEGG enrichment, were performed to identify treatment-related changes. Results: Andai therapy resulted in significant changes in gut microbiota, including an increase in Conclusion: Andai therapy modulates gut microbiota and metabolic pathways related to depression, suggesting its potential as a complementary treatment. Larger studies and multi-omics approaches are necessary to explore these mechanisms further.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.